Cargando…
Two Cases of Hepatocellular Carcinoma Arising Over 20 Years after a Sustained Virologic Response Following Interferon Therapy for Chronic Hepatitis C
The development of hepatocellular carcinoma (HCC) after a sustained virologic response (SVR) due to interferon (IFN) therapy for hepatitis C virus infection remains a serious problem. We herein report 2 cases of HCC that developed more than 20 years after SVR with IFN therapy for chronic hepatitis C...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474997/ https://www.ncbi.nlm.nih.gov/pubmed/32350199 http://dx.doi.org/10.2169/internalmedicine.4479-20 |
_version_ | 1783579431858601984 |
---|---|
author | Takata, Kazuhide Ishii, Fuminori Uchida, Yotaro Fukuda, Hiromi Yamauchi, Ryo Umeda, Kaoru Tsuchiya, Naoaki Tanaka, Takashi Yokoyama, Keiji Morihara, Daisuke Takeyama, Yasuaki Shakado, Satoshi Sakisaka, Shotaro Hirai, Fumihito |
author_facet | Takata, Kazuhide Ishii, Fuminori Uchida, Yotaro Fukuda, Hiromi Yamauchi, Ryo Umeda, Kaoru Tsuchiya, Naoaki Tanaka, Takashi Yokoyama, Keiji Morihara, Daisuke Takeyama, Yasuaki Shakado, Satoshi Sakisaka, Shotaro Hirai, Fumihito |
author_sort | Takata, Kazuhide |
collection | PubMed |
description | The development of hepatocellular carcinoma (HCC) after a sustained virologic response (SVR) due to interferon (IFN) therapy for hepatitis C virus infection remains a serious problem. We herein report 2 cases of HCC that developed more than 20 years after SVR with IFN therapy for chronic hepatitis C. The patients were 89- and 72-year-old men with HCC that developed 24-25 years after an SVR with IFN therapy. These patients regularly underwent imaging examinations; therefore, the HCC was detected in the early stage, when it was still curable. Both cases suggest that long-term surveillance after an SVR is effective for the detection of HCC, and radical treatment is possible. |
format | Online Article Text |
id | pubmed-7474997 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Japanese Society of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-74749972020-09-18 Two Cases of Hepatocellular Carcinoma Arising Over 20 Years after a Sustained Virologic Response Following Interferon Therapy for Chronic Hepatitis C Takata, Kazuhide Ishii, Fuminori Uchida, Yotaro Fukuda, Hiromi Yamauchi, Ryo Umeda, Kaoru Tsuchiya, Naoaki Tanaka, Takashi Yokoyama, Keiji Morihara, Daisuke Takeyama, Yasuaki Shakado, Satoshi Sakisaka, Shotaro Hirai, Fumihito Intern Med Case Report The development of hepatocellular carcinoma (HCC) after a sustained virologic response (SVR) due to interferon (IFN) therapy for hepatitis C virus infection remains a serious problem. We herein report 2 cases of HCC that developed more than 20 years after SVR with IFN therapy for chronic hepatitis C. The patients were 89- and 72-year-old men with HCC that developed 24-25 years after an SVR with IFN therapy. These patients regularly underwent imaging examinations; therefore, the HCC was detected in the early stage, when it was still curable. Both cases suggest that long-term surveillance after an SVR is effective for the detection of HCC, and radical treatment is possible. The Japanese Society of Internal Medicine 2020-04-30 2020-08-01 /pmc/articles/PMC7474997/ /pubmed/32350199 http://dx.doi.org/10.2169/internalmedicine.4479-20 Text en Copyright © 2020 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Takata, Kazuhide Ishii, Fuminori Uchida, Yotaro Fukuda, Hiromi Yamauchi, Ryo Umeda, Kaoru Tsuchiya, Naoaki Tanaka, Takashi Yokoyama, Keiji Morihara, Daisuke Takeyama, Yasuaki Shakado, Satoshi Sakisaka, Shotaro Hirai, Fumihito Two Cases of Hepatocellular Carcinoma Arising Over 20 Years after a Sustained Virologic Response Following Interferon Therapy for Chronic Hepatitis C |
title | Two Cases of Hepatocellular Carcinoma Arising Over 20 Years after a Sustained Virologic Response Following Interferon Therapy for Chronic Hepatitis C |
title_full | Two Cases of Hepatocellular Carcinoma Arising Over 20 Years after a Sustained Virologic Response Following Interferon Therapy for Chronic Hepatitis C |
title_fullStr | Two Cases of Hepatocellular Carcinoma Arising Over 20 Years after a Sustained Virologic Response Following Interferon Therapy for Chronic Hepatitis C |
title_full_unstemmed | Two Cases of Hepatocellular Carcinoma Arising Over 20 Years after a Sustained Virologic Response Following Interferon Therapy for Chronic Hepatitis C |
title_short | Two Cases of Hepatocellular Carcinoma Arising Over 20 Years after a Sustained Virologic Response Following Interferon Therapy for Chronic Hepatitis C |
title_sort | two cases of hepatocellular carcinoma arising over 20 years after a sustained virologic response following interferon therapy for chronic hepatitis c |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474997/ https://www.ncbi.nlm.nih.gov/pubmed/32350199 http://dx.doi.org/10.2169/internalmedicine.4479-20 |
work_keys_str_mv | AT takatakazuhide twocasesofhepatocellularcarcinomaarisingover20yearsafterasustainedvirologicresponsefollowinginterferontherapyforchronichepatitisc AT ishiifuminori twocasesofhepatocellularcarcinomaarisingover20yearsafterasustainedvirologicresponsefollowinginterferontherapyforchronichepatitisc AT uchidayotaro twocasesofhepatocellularcarcinomaarisingover20yearsafterasustainedvirologicresponsefollowinginterferontherapyforchronichepatitisc AT fukudahiromi twocasesofhepatocellularcarcinomaarisingover20yearsafterasustainedvirologicresponsefollowinginterferontherapyforchronichepatitisc AT yamauchiryo twocasesofhepatocellularcarcinomaarisingover20yearsafterasustainedvirologicresponsefollowinginterferontherapyforchronichepatitisc AT umedakaoru twocasesofhepatocellularcarcinomaarisingover20yearsafterasustainedvirologicresponsefollowinginterferontherapyforchronichepatitisc AT tsuchiyanaoaki twocasesofhepatocellularcarcinomaarisingover20yearsafterasustainedvirologicresponsefollowinginterferontherapyforchronichepatitisc AT tanakatakashi twocasesofhepatocellularcarcinomaarisingover20yearsafterasustainedvirologicresponsefollowinginterferontherapyforchronichepatitisc AT yokoyamakeiji twocasesofhepatocellularcarcinomaarisingover20yearsafterasustainedvirologicresponsefollowinginterferontherapyforchronichepatitisc AT moriharadaisuke twocasesofhepatocellularcarcinomaarisingover20yearsafterasustainedvirologicresponsefollowinginterferontherapyforchronichepatitisc AT takeyamayasuaki twocasesofhepatocellularcarcinomaarisingover20yearsafterasustainedvirologicresponsefollowinginterferontherapyforchronichepatitisc AT shakadosatoshi twocasesofhepatocellularcarcinomaarisingover20yearsafterasustainedvirologicresponsefollowinginterferontherapyforchronichepatitisc AT sakisakashotaro twocasesofhepatocellularcarcinomaarisingover20yearsafterasustainedvirologicresponsefollowinginterferontherapyforchronichepatitisc AT hiraifumihito twocasesofhepatocellularcarcinomaarisingover20yearsafterasustainedvirologicresponsefollowinginterferontherapyforchronichepatitisc |